BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25138686)

  • 1. PML nuclear bodies: regulation, function and therapeutic perspectives.
    Sahin U; Lallemand-Breitenbach V; de Thé H
    J Pathol; 2014 Nov; 234(3):289-91. PubMed ID: 25138686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.
    Sahin U; de Thé H; Lallemand-Breitenbach V
    Nucleus; 2014; 5(6):499-507. PubMed ID: 25482067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
    Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
    Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.
    Tessier S; Martin-Martin N; de Thé H; Carracedo A; Lallemand-Breitenbach V
    Antioxid Redox Signal; 2017 Mar; 26(9):432-444. PubMed ID: 27758112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
    Sarkari F; Wang X; Nguyen T; Frappier L
    PLoS One; 2011 Jan; 6(1):e16598. PubMed ID: 21305000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
    Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease.
    Zimber A; Nguyen QD; Gespach C
    Cell Signal; 2004 Oct; 16(10):1085-104. PubMed ID: 15240004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PML is a ROS sensor activating p53 upon oxidative stress.
    Niwa-Kawakita M; Ferhi O; Soilihi H; Le Bras M; Lallemand-Breitenbach V; de Thé H
    J Exp Med; 2017 Nov; 214(11):3197-3206. PubMed ID: 28931625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML nuclear bodies.
    Lallemand-Breitenbach V; de Thé H
    Cold Spring Harb Perspect Biol; 2010 May; 2(5):a000661. PubMed ID: 20452955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML nuclear bodies and apoptosis.
    Takahashi Y; Lallemand-Breitenbach V; Zhu J; de Thé H
    Oncogene; 2004 Apr; 23(16):2819-24. PubMed ID: 15077145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of promyelocytic leukemia protein in host antiviral defense.
    Geoffroy MC; Chelbi-Alix MK
    J Interferon Cytokine Res; 2011 Jan; 31(1):145-58. PubMed ID: 21198351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
    Sanchez-Pulido L; Valencia A; Rojas AM
    Trends Biochem Sci; 2007 Sep; 32(9):400-6. PubMed ID: 17693089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.